The impact of European legislative and technology measures to reduce air pollutants on air quality, human health and climate (11 page pdf, S T Turnock, E W Butt, T B Richardson, G W Mann, C L Reddington1, P M Forster, J Haywood, M Crippa, G Janssens-Maenhout, C E Johnson, Environ. Res. Lett., Feb 12, 2016)
Today we review a paper that estimates, using two simulation models, how many premature deaths were prevented with and without the technology and regulatory changes over the period from 1970 to 2010. Results indicate that the adoption of the PM2.5 concentration to 15 μgm−3 prevented 80,000 deaths and economic benefits of $232 each year. Mitigation measures reduced the premature deaths by 3 to 4 premature deaths annually per 10 000 people in central and eastern Europe ..and 5 to 6 premature deaths annually per 10 000 people in south eastern Europe (Romania and Bulgaria).
“We used a coupled composition-climate model to simulate the impacts of European air quality legislation and technology measures implemented between 1970 and 2010.”
“European emissions of sulphur dioxide, black carbon (BC) and organic carbon in 2010 are 53%, 59% and 32% lower respectively compared to emissions that would have occurred in 2010 in the absence of legislative and technology measures.”
“The reduction inPM2.5 concentrations is calculated to have prevented 80 000 … premature deaths annually across the European Union, resulting in a perceived financial benefit to society of US$232 billion annually…Exposure to fine particulate matter (PM2.5) is responsible for ∼3.3 million deaths worldwide each year“
“Reducing PM2.5 concentrations across more than 20 European cities to 15 μgm−3 was calculated to reduce the number of annual premature deaths by nearly 17 000”
“Air pollutant mitigation measures prevent 3 to 4 premature deaths annually per 10 000 people in central and eastern Europe ..and 5 to 6 premature deaths annually per 10 000 people in south eastern Europe (Romania and Bulgaria), where the largest reductions in PM2.5 occurred”
“These improvements to health have had a perceived economic benefit to society estimated to be US $232 billion annually, representing 1.4% of the EU’s GDP in 2010.”